From other sites
Immune Pharmaceuticals : Vista Partners Initiates Coverage on Immune Pharmaceuticals Inc. (NasdaqCM: IMNP); $6.00 Price Targetat 4-traders.com (Jul 23, 2015)
at 4-traders.com (Jul 17, 2015)
IMMUNE PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)at 4-traders.com (May 15, 2015)
Immune Pharmaceuticals : and STC Biologics announce strategic partnership to accelerate the development of NanomAbs®at 4-traders.com (May 4, 2015)
IMNP vs. ETF Alternatives
Immune Pharmaceuticals Inc is a clinical stage biopharmaceutical company specializing in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer.
Other News & PR